Imidazole compounds for the treatment of neurological disorders
US7781435B2 · kind B2 · utility
1Cited by
19References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2006 |
| Grant date | Aug 24, 2010 |
| Priority date | — |
| Expiry date | Nov 25, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula Iwherein R1, R2, R3, R4, R6, R7 and A are as defined. Compounds of Formula I have activity inhibiting production of Aβ-peptide. The invention also relates to pharmaceutical compositions and methods for treating diseases and disorders, for example, neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal comprising compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.